LB-46 in angina pectoris. A critique of anti-anginal drug assessment.

Ganeshan, K P; Xavier, K B.
Indian Heart J ; 1972 Jun; 24(): Suppl 1:197-20
Artículo en Inglés | IMSEAR | ID: sea-3218

Documentos relacionados

  1. LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
  2. [Hyperthyroidism caused by amiodarone. Apropos of 4 clinical cases].
  3. [Comparative evaluation of the clinical action of a series of beta-adrenergic blockaders].
  4. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
  5. Clinical relevance of intrinsic sympathomimetic activity of beta blockers.
  6. Beta-Blockers and Calcium Channel Blockers: First Line Agents.
  7. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
  8. [Beta-blockers in effort angina].
  9. Nadolol compared to propranolol for treating chronic stable angina pectoris.
  10. Propranolol for Angina Pectoris.